Home / Business News (page 105)

Business News

Quest Diagnostics and CDC Partner to Improve Hepatitis Diagnosis and Treatment

Quest Diagnostics is collaborating with the Centers for Disease Control and Prevention (CDC) to identify trends in screening, diagnosis and treatment of four strains of viral hepatitis in the US. Quest Diagnostics will provide CDC researchers with analytics and access to its national database of de-identified clinical testing hepatitis data. …

Read More »

Syncona and UCL Business Form Cancer Immunotherapy Company Autolus

Backed with roughly $45.5 million, Investment company Syncona and UCL Business, the wholly-owned technology transfer company of University College London, have launched the latest CAR T upstart, Autolus Limited. According to the companies, Autolus is a biopharmaceutical company focused on the development and commercialization of next-generation engineered T-cell therapies for …

Read More »

European Health Regulators to Review AstraZeneca’s Investigational Gout Drug

The European Medicines Agency (EMA) has accepted AstraZeneca’s marketing authorization application for its investigational gout drug, which the company acquired through its acquisition of Ardea Biosciences. AstraZeneca said that the EMA accepted its application for lesinurad 200mg tablets for the chronic treatment of hyperuricaemia in gout patients. Lesinurad is a …

Read More »

Kite Pharma and Tel Aviv Sourasky Medical Center Expand Agreement for Novel CAR T Cell Therapy Products

Today, Kite Pharma, Inc. announced that it has expanded its immuno-oncology partnership with Tel Aviv Sourasky Medical Center. The US-based biopharmaceutical company expanded its agreement with the Israeli university to research and develop novel approaches to CAR T cell therapy, the technology underlying Kite’s most advanced programs in cancer immunotherapy. …

Read More »

Strides Enters Licensing Deal with Gilead for HIV Drug

Indian generic drugmaker Strides Arcolab recently announced that it has entered a licensing deal to distribute Gilead Sciences’ HIV drug. The company said that it has entered into a licensing agreement with Gilead, under which Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide (TAF), both …

Read More »

CytRx Climbs as FDA Removes Clinical Hold on Trials Evaluating its Cancer Candidate

Today, CytRx Corporation announced that US health regulators removed a partial clinical hold on its late-stage cancer trials, causing shares to jump ten percent. The company said that the US Food and Drug Administration (FDA) has removed the partial clinical hold on its aldoxorubicin clinical trials, and enrollment and dosing …

Read More »

Roche Expands its Rare Disease Portfolio with Trophos Acquisition

Swiss drugmaker Roche has signed an agreement to acquire privately-held Trophos for up to $545 million. The acquisition will provide Roche with Trophos’ candidate for the rare and debilitating spinal muscular atrophy (SMA). Trophos’ proprietary screening platform generated olesoxime (TRO19622), which is in mid-stage development for SMA. SMA is a …

Read More »